1
Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)
Condition(s):Multiple Sclerosis, Secondary ProgressiveLast Updated:February 24, 2020Completed
Domperidone as an Intervention: 77 Clinical Trials, Page 1 of 8
Hide Studies Not Open or Pending
2
Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:October 8, 2019Completed
3
Domperidone and Risk of Serious Cardiac Events in Postpartum Women
Condition(s):Ventricular Tachyarrhythmia; Sudden Cardiac Death; Lactation; Breast FeedingLast Updated:July 7, 2021Completed
4
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Condition(s):Digestive System DiseaseLast Updated:May 16, 2017Completed
5
Domperidone for Refractory Gastrointestinal Disorders
Condition(s):GastroparesisLast Updated:August 18, 2016Unknown status
6
Domperidone and Risk of Sudden Cardiac Death
Condition(s):Parkinson’s DiseaseLast Updated:April 19, 2016Completed
7
Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy
Condition(s):Capsule Endoscopy; Pediatric DisorderLast Updated:December 17, 2018Completed
8
Compassionate Use of Domperidone for Refractory Gastroparesis
Condition(s):GERD; Gastroesophageal Reflux; GastroparesisLast Updated:May 24, 2022Recruiting
9
The Use of Domperidone for Gastroparesis
Condition(s):GastroparesisLast Updated:March 19, 2013Withdrawn
10
Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis
Condition(s):Patients With Gastroparesis Who Have Failed Standard TherapyLast Updated:February 9, 2018Completed